Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Unknown Primary

Clinical trial condition

Neoplasms, Unknown Primary

Explore clinical trials studying Neoplasms, Unknown Primary. Study availability and eligibility vary by location and protocol.

75 public trials 13 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Unknown Primary trial results

Completed

Genomic Testing and Resulting Medical Decisions

NCT03301493

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +70 more
Locations: IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria

Innere Medizin II, LKH Feldkirch Feldkirch, Austria

Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria

Medizinische Universität Innsbruck Innsbruck, Austria

View Trial Details

Completed

The Registry of Oncology Outcomes Associated With Testing and Treatment

NCT04028479

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
Locations: Teton Cancer Institute Idaho Falls, Idaho, United States

Oncology and Hematology of South Texas Laredo, Texas, United States

View Trial Details

Completed

Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid Biomarkers

NCT04750109

Conditions: Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
Locations: UCL Cancer Institute London, United Kingdom

Royal United Hospitals Bath NHS Foundation Trust Bath, United Kingdom

Velindre Cancer Centre Cardiff, United Kingdom

Edinburgh Cancer Centre Edinburgh, United Kingdom

View Trial Details

Completed

Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown Primary

NCT05841966

Conditions: Cancer of Unknown Primary Site, Carcinoma, Carcinoma, Squamous Cell, +11 more
Locations: Århus University Hospital, Department of Otorhinolaryngology, Head & Neck Surgery Aarhus, Denmark

Rigshospitalet, Department of Otorhinolaryngology, Head & Neck Surgery & Audiology Copenhagen, Denmark

View Trial Details

Completed

A Study of Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP)

NCT02607202

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms, Unknown Primary, +4 more
Locations: Investigative Clinical Oncology (Oncologia Medica 2) Candiolo, Turin, Italy

AOU Policlinoco S Orsola - Malpighi Bologna, Italy

Ospedali Galliera Genova, Italy

Istituto Europeo di Oncologia - IEO Milan, Italy

View Trial Details

Completed

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

NCT04456140

Conditions: Brain Diseases, Brain Neoplasms, Breast Carcinoma, +33 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Completed

Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine

NCT01845337

Conditions: Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +19 more
Locations: Edinburgh Cancer Centre Edinburgh, Scotland, United Kingdom

View Trial Details

Completed

Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS

NCT04189107

Conditions: Agnosia, Analgesia, Cancer of Head and Neck, +26 more
Locations: Department of Otorhinolaryngology, Head and Neck Surgery & Audiology Copenhagen, Denmark

View Trial Details

Completed

APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

NCT03053466

Conditions: Cancer of Unknown Primary Site, Genomic Instability, Microsatellite Instability, +9 more
Locations: Chris O'Brien Lifehouse Camperdown, New South Wales, Australia

Cabrini Health Limited Malvern, Victoria, Australia

Peter MaCallum Cancer Centre Melbourne, Victoria, Australia

Nucleus Network Melbourne, Victoria, Australia

View Trial Details

Completed

Tissue-of-origin Directing Therapy in Patients With Cancer of Unknown Primary

NCT03278600

Conditions: Cancer of Unknown Primary Site, Neoplasm Metastasis, Neoplasms, +4 more
Locations: Fudan University Cancer Hospital Shanghai, China

View Trial Details